Access to medicines, care, and services for multiple sclerosis patients in Central and Eastern European countries: a comparative analysis
The study revealed disparities in health care and services for MS patients across the countries surveyed. Addressing these disparities and the need for targeted interventions to ensure equitable access is critical. Further research is needed to find effective solutions.
Authors
- Ivana Tadić (ORCID: https://orcid.org/0000-0001-5488-9261)
- Guenka Ivanova Petrova (ORCID: https://orcid.org/0000-0001-8116-5138)
- Dominik Grega (ORCID: https://orcid.org/0000-0001-5336-3794)
- Przemysław Holko (ORCID: https://orcid.org/0000-0002-6821-4078)
- Yoana Seitaridou
- Maria Kamusheva (ORCID: https://orcid.org/0000-0002-4379-5283)
- Sorin Paveliu
- Ivana Stević (ORCID: https://orcid.org/0000-0001-8880-7092)
- Teodora Chamova (ORCID: https://orcid.org/0000-0001-5142-5007)
- Agnes Männik
Institutions
- Titu Maiorescu University (RO)
- Jagiellonian University (PL)
- Universität Innsbruck (AT)
- Masaryk University (CZ)
- Alexandrovska Hospital (BG)
- Medical University of Sofia (BG)
- University of Belgrade (RS)
- University of Tartu (EE)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1080/14737167.2025.2493131
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00